{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:38:14Z","timestamp":1792636694644,"version":"4.5.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>While dyslipidemia is a well-established systemic risk factor in glomerular diseases, the clinical and histopathological relevance of compartmental intrarenal lipid deposition in primary glomerulonephritis (GN) remains insufficiently elucidated. Recent evidence suggests that lipid accumulation may directly contribute to glomerular and tubulointerstitial injury via pro-inflammatory and oxidative mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this single-center, cross-sectional analysis, we examined 31 adult patients with biopsy-proven primary GN\u2014IgA nephropathy (IgAN), membranous nephropathy (MN), and focal segmental glomerulosclerosis\/minimal change disease (FSGS\/MCD)\u2014diagnoses. Renal tissue specimens were subjected to Oil Red O staining to quantify lipid accumulation within tubular, interstitial, and vascular compartments. Clinical parameters and laboratory indices were assessed. Histopathologic correlations were performed using Oxford MEST-C classification (for IgAN) and Interstitial Fibrosis and Tubular Atrophy (IFTA) scoring.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Intrarenal lipid deposition was prevalent across compartments: tubular (84%), interstitial (74%), and vascular (61%). In IgAN patients, both the extent and morphology of tubular steatosis were strongly correlated with composite MEST-C scores (P &amp;lt; .01). In MN, tubular lipid burden was significantly associated with systolic blood pressure and proteinuria levels (P &amp;lt; .01). Notably, interstitial and vascular lipid accumulation demonstrated positive associations independent of systemic lipid levels. In FSGS\/MCD cases, tubular steatosis correlated with both low density lipoprotein (LDL) and interstitial lipid scores (P &amp;lt; .01), whereas vascular lipid presence was linked to the degree of proteinuria (P &amp;lt; .05).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Intrarenal lipid deposition is a prevalent histological finding in primary GN and correlates with both structural injury and clinical disease burden. These findings support the hypothesis that local lipid accumulation may represent a pathophysiologically relevant biomarker of disease activity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/joneph\/aajag139","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T12:05:45Z","timestamp":1778673945000},"page":"1470-1478","source":"Crossref","is-referenced-by-count":0,"title":["Renal steatosis in the tubulointerstitial compartment in primary glomerulopathies: biopsy evidence and correlation with disease severity"],"prefix":"10.1093","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2740-629X","authenticated-orcid":false,"given":"Gorkem","family":"Celebi","sequence":"first","affiliation":[{"name":"Department of Nephrology, Hacettepe University Faculty of Medicine , Ankara ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3724-4649","authenticated-orcid":false,"given":"Ozan","family":"Sakir","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hacettepe University Faculty of Medicine , Ankara ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9927-1246","authenticated-orcid":false,"given":"Meral","family":"Uner","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hacettepe University Faculty of Medicine , Ankara ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0076-8293","authenticated-orcid":false,"given":"Arzu","family":"Saglam","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hacettepe University Faculty of Medicine , Ankara ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5832-0336","authenticated-orcid":false,"given":"Rahmi","family":"Yilmaz","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hacettepe University Faculty of Medicine , Ankara ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5787-1048","authenticated-orcid":false,"given":"Hasan","family":"Yeter","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hacettepe University Faculty of Medicine , Ankara ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"2026102121375647800_aajag139-B1","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.mpmed.2019.07.004","article-title":"Primary glomerular disease","volume":"47","author":"Mathieson","year":"2019","journal-title":"Medicine (Baltimore)."},{"key":"2026102121375647800_aajag139-B2","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","article-title":"KDIGO 2021 clinical practice guideline for the management of glomerular diseases","volume":"100","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group","year":"2021","journal-title":"Kidney Int"},{"key":"2026102121375647800_aajag139-B3","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1002\/j.2040-4603.2013.tb00511.x","article-title":"Immune and inflammatory role in renal disease","volume":"3","author":"Imig","year":"2013","journal-title":"Compr Physiol"},{"key":"2026102121375647800_aajag139-B4","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1093\/ndt\/15.8.1127","article-title":"Role of reactive oxygen species in glomerulonephritis","volume":"15","author":"Gwinner","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"2026102121375647800_aajag139-B5","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/j.1440-1797.2008.01018.x","article-title":"Review article: adiponectin: its role in kidney disease","volume":"13","author":"Shen","year":"2008","journal-title":"Nephrology (Carlton)"},{"key":"2026102121375647800_aajag139-B6","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s10735-008-9198-6","article-title":"Adiponectin stimulates phosphorylation of AMP-activated protein kinase alpha in renal glomeruli","volume":"39","author":"Cammisotto","year":"2008","journal-title":"J Mol Histol"},{"key":"2026102121375647800_aajag139-B7","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/jcp.22726","article-title":"Protective effects of adiponectin against renal ischemia-reperfusion injury via prostacyclin-PPAR\u03b1-heme oxygenase-1 signaling pathway","volume":"227","author":"Cheng","year":"2012","journal-title":"J Cell Physiol"},{"key":"2026102121375647800_aajag139-B8","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/S0140-6736(82)91513-6","article-title":"Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease","volume":"2","author":"Moorhead","year":"1982","journal-title":"Lancet"},{"key":"2026102121375647800_aajag139-B9","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S2213-8587(14)70065-8","article-title":"Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease","volume":"2","author":"de Vries","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026102121375647800_aajag139-B10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1159\/000533507","article-title":"Thickened perirenal fat predicts poor renal outcome in patients with immunoglobulin A nephropathy: a population-based retrospective cohort study","volume":"10","author":"Hu","year":"2024","journal-title":"Kidney Dis (Basel)"},{"key":"2026102121375647800_aajag139-B11","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1016\/j.biochi.2013.07.017","article-title":"Ectopic lipid accumulation: a potential cause for metabolic disturbances and a contributor to the alteration of kidney function","volume":"95","author":"Guebre-Egziabher","year":"2013","journal-title":"Biochimie"},{"key":"2026102121375647800_aajag139-B12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/qjmed\/hcp158","article-title":"Pathogenesis of non-alcoholic fatty liver disease","volume":"103","author":"Dowman","year":"2010","journal-title":"QJM"},{"key":"2026102121375647800_aajag139-B13","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/3680397","article-title":"Recent progress on lipid intake and chronic kidney disease","volume":"2020","author":"Pei","year":"2020","journal-title":"Biomed Res Int"},{"key":"2026102121375647800_aajag139-B14","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.amjmed.2023.06.025","article-title":"The fatty kidney and beyond: a silent epidemic","volume":"136","author":"Hti Lar Seng","year":"2023","journal-title":"Am J Med"},{"key":"2026102121375647800_aajag139-B15","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/608397","article-title":"Inflammation and oxidative stress in obesity-related glomerulopathy","volume":"2012","author":"Tang","year":"2012","journal-title":"Int J Nephrol"},{"key":"2026102121375647800_aajag139-B16","doi-asserted-by":"publisher","DOI":"10.3390\/nu11040722","article-title":"Lipid accumulation and chronic kidney disease","volume":"11","author":"Gai","year":"2019","journal-title":"Nutrients"},{"key":"2026102121375647800_aajag139-B17","doi-asserted-by":"publisher","DOI":"10.3390\/cells9061342","article-title":"Reactive oxygen species and redox signaling in chronic kidney disease","volume":"9","author":"Irazabal","year":"2020","journal-title":"Cells"},{"key":"2026102121375647800_aajag139-B18","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1194\/jlr.M076216","article-title":"Inflammatory stress promotes the development of obesity-related chronic kidney disease via CD36 in mice","volume":"58","author":"Yang","year":"2017","journal-title":"J Lipid Res"},{"key":"2026102121375647800_aajag139-B19","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.kint.2017.02.003","article-title":"Oxford classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group","volume":"91","author":"Trimarchi","year":"2017","journal-title":"Kidney Int"},{"key":"2026102121375647800_aajag139-B20","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2478\/rjim-2020-0025","article-title":"Combining clinical features and MEST-C score in IgA nephropathy may be a better determinant of kidney survival","volume":"58","author":"Yeter","year":"2020","journal-title":"Rom J Intern Med"},{"key":"2026102121375647800_aajag139-B21","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.freeradbiomed.2022.06.224","article-title":"Association of redox and inflammation-related biomarkers with prognosis in IgA nephropathy: a prospective observational study","volume":"188","author":"Apeland","year":"2022","journal-title":"Free Radic Biol Med"},{"key":"2026102121375647800_aajag139-B22","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2019.00241","article-title":"Immune-monitoring disease activity in primary membranous nephropathy","volume":"6","author":"Cravedi","year":"2019","journal-title":"Front Med (Lausanne)"},{"key":"2026102121375647800_aajag139-B23","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14030761","article-title":"Membranous nephropathy","volume":"14","author":"Ponticelli","year":"2025","journal-title":"J Clin Med."},{"key":"2026102121375647800_aajag139-B24","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1430451","article-title":"THSD7A-associated membranous nephropathy involves both complement-mediated and autonomous podocyte injury","volume":"15","author":"Liu","year":"2024","journal-title":"Front Pharmacol"},{"key":"2026102121375647800_aajag139-B25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.freeradbiomed.2023.07.014","article-title":"Oxidative stress and inflammation are mediated via aryl hydrocarbon receptor signalling in idiopathic membranous nephropathy","volume":"207","author":"Wang","year":"2023","journal-title":"Free Radic Biol Med"},{"key":"2026102121375647800_aajag139-B26","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8163298","article-title":"A novel insight into the role of PLA2R and THSD7A in membranous nephropathy","volume":"2021","author":"Zhang","year":"2021","journal-title":"J Immunol Res"},{"key":"2026102121375647800_aajag139-B27","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1080\/0886022X.2018.1487864","article-title":"Urinary protein and renal prognosis in idiopathic membranous nephropathy: a multicenter retrospective cohort study in Japan","volume":"40","author":"Yamaguchi","year":"2018","journal-title":"Ren Fail"},{"key":"2026102121375647800_aajag139-B28","first-page":"66","article-title":"Endothelial dysfunction in the nephrotic syndrome","volume":"60","author":"Caraba","year":"2007","journal-title":"Med Pregl"},{"key":"2026102121375647800_aajag139-B29","doi-asserted-by":"publisher","first-page":"465","DOI":"10.2174\/1874467215666220616152312","article-title":"Nephrotic syndrome and renin-angiotensin system: pathophysiological role and therapeutic potential","volume":"16","author":"Dos Anjos","year":"2023","journal-title":"Curr Mol Pharmacol"},{"key":"2026102121375647800_aajag139-B30","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.34067\/KID.0000000000000499","article-title":"Minimal change disease and FSGS are a spectrum of a single disease within immune-mediated nephrotic syndrome","volume":"5","author":"Sim","year":"2024","journal-title":"Kidney360"},{"key":"2026102121375647800_aajag139-B31","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1093\/ndt\/gfp500","article-title":"Recurrence of nephrotic syndrome after transplantation in a mixed population of children and adults: course of glomerular lesions and value of the Columbia classification of histological variants of focal and segmental glomerulosclerosis (FSGS)","volume":"25","author":"Canaud","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"2026102121375647800_aajag139-B32","volume-title":"Heptinstall's Pathology of the Kidney Volume 1 and 2, 7e","author":"Jennette","year":"2015"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/joneph\/article-pdf\/39\/7\/1470\/70254034\/aajag139.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/joneph\/article-pdf\/39\/7\/1470\/70254034\/aajag139.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:38:06Z","timestamp":1792633086000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/39\/7\/1470\/8743991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":32,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,28]]},"published-print":{"date-parts":[[2026,10,22]]}},"URL":"https:\/\/doi.org\/10.1093\/joneph\/aajag139","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,7,28]]}}}